Related Experiment Video
Updated: Jun 24, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface
Johanna M Rodriguez1, Nathan T Ross, William P Katt
1Department of Chemistry, Yale University, New Haven, Connecticut 06520, USA.
Chemmedchem
|March 31, 2009
Summary
Novel benzoylurea compounds effectively inhibit the Bcl-x(L)/Bak interaction, a key target in cancer therapy. These alpha-helix mimetics disrupt apoptosis in cancer cells by binding to Bcl-x(L).
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- The interaction between B-cell lymphoma-extra large (Bcl-xL) and Bcl-2-associated X protein (Bak) is crucial for regulating apoptosis.
- Inhibiting this protein-protein interaction is a promising strategy for developing novel cancer therapeutics.
Purpose of the Study:
- To design and synthesize a new class of alpha-helix mimetics targeting the Bcl-xL/Bak interaction.
- To evaluate the efficacy of these novel compounds in disrupting the Bcl-xL/Bak complex.
Main Methods:
- Rational design of alpha-helix mimetics based on a benzoylurea scaffold.
- Synthesis and characterization of benzoylurea derivatives.
- Biophysical assays including fluorescence polarization competition, isothermal titration calorimetry, and (15)N-HSQC to assess binding to Bcl-xL.
Main Results:
- Novel benzoylurea derivatives were synthesized, exhibiting improved solubility and synthetic feasibility.
- These compounds mimic key residues of the Bak alpha-helix, binding to the hydrophobic pocket of Bcl-xL.
- Low micromolar inhibition and dissociation constants were observed, demonstrating effective disruption of the Bcl-xL/Bak interaction.
Conclusions:
- Benzoylurea-based alpha-helix mimetics represent a viable strategy for targeting the Bcl-xL/Bak interaction.
- These compounds show potential as therapeutic agents for inducing apoptosis in cancer cells.
Related Concept Videos
01:37NMR Spectroscopy of Benzene Derivatives
Simple unsubstituted benzene has six aromatic protons, all chemically equivalent. Therefore, benzene exhibits only a singlet peak at δ 7.3 ppm in the 1H NMR spectrum. The observed shift is far downfield because the aromatic ring current strongly deshields the protons. Any substitution on the benzene ring makes the aromatic protons nonequivalent, and the protons split each other. The peak is, therefore, no longer a singlet and the splitting pattern and their associated coupling constants depend...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...